This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Laryngismus
and you are
between 18 and 60
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.

Provided treatments

  • Drug: Remifentanil 1
  • Drug: Control
  • Drug: Remifentanil 2

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01456299. The sponsor of the trial is Gachon University Gil Medical Center and it is looking for 102 volunteers for the current phase.
Official trial title:
Target-controlled Infusion of Remifentanil for Laryngeal Mask Airway Insertion During Sevoflurane Induction in Adults